#weight-loss-competition

[ follow ]
#glp-1-drugs #revenue-and-earnings-growth #manufacturing-investment
Business
from24/7 Wall St.
2 days ago

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Dec 2025)

Eli Lilly's stock surged due to GLP‑1 drugs, strong revenues and earnings, pipeline and manufacturing investment, but faces capacity limits and intense weight‑loss competition.
[ Load more ]